[ Price : $8.95]
Syndax Pharmaceuticals plans an NDA submission by year end for revumenib, a first-in-class menin inhibitor for treating patients w...[ Price : $8.95]
Federal Register notice: FDA posts a summary of the comments received for the Methodological Challenges Related to Patient Experie...[ Price : $8.95]
The U.S. Supreme Court agrees to hear arguments in an appeal of the 5th Circuit Court of Appeals decision that places restrictions...[ Price : $8.95]
FDA says it is creating a nine-member Genetic Metabolic Diseases Advisory Committee.[ Price : $8.95]
Public Citizen calls on FDA to strengthen the Botox Boxed Warning to highlight the risk of systemic iatrogenic botulism and relate...[ Price : $8.95]
FDA publishes a draft guidance on the Advanced Manufacturing Technologies Designation Program and its benefits for drug developmen...[ Price : $8.95]
Utah-based medical device company Dolor Technologies settles False Claims Act charges with the federal government over a device it...[ Price : $8.95]
FDA publishes a draft guidance with clinical pharmacology considerations to assist industry in developing peptide drug products.